Cowen Reiterates Outperform as Ulta Salon (ULTA) Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Unusual 11 Mid-Day Movers 10/13: (AEZS) (OCUL) (CTRV) High; (FLDM) (APTO) (FLKS) Low
October 13, 2016 12:49 PM EDTFluidigm Corporation (Nasdaq: FLDM) 27.0% LOWER; announced preliminary revenue for the third quarter ended September 30, 2016. Estimated total revenue for the third quarter of 2016, based on managements preliminary analysis, was approximately $22.2 million. (The consensus was at $29.3 million.)
Aptose Biosciences Inc. (Nasdaq: APTO) 21.0% LOWER; received a response from the U.S. Food and Drug Administration (FDA) regarding the clinical hold of Aptoses Phase 1b clinical trial of APTO-253 in patients with hematologic cancers requesting additional information and informing... More
Stifel Sees Ulta Salon's (ULTA) Updated Q3 Comps Growth Outlook as Notable; Other Metrics Inline
October 13, 2016 11:30 AM EDTStifel affirms Ulta Salon, Cosmetics, & Fragrance (Nasdaq: ULTA) at Hold with a price target of $277 following updated guidance issued ahead of the company's investor meeting today.
Analyst Mark Astrachan offered the following... More
Pre-Open Stock Movers 10/13: (OCUL) (ESRP) (ULTA) Higher; (FLDM) (TGTX) (MELI) Lower (more...)
October 13, 2016 9:20 AM EDTToday's Pre-Open Stock Movers
ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) 30.6% HIGHER; reported positive interim data for CMX157, the Company's highly potent prodrug of tenofovir, from its ongoing Phase 2a multiple ascending dose clinical study. The head-to-head study is the first evaluation of CMX157 in HBV patients, and directly compares CMX157 to tenofovir disoproxil fumarate (TDF, Gilead's Viread®) in... More
Ulta Salon (ULTA) Boosts Q3, FY16 Outlook into Analyst, Investor Conference
October 13, 2016 8:06 AM EDTUlta Beauty (Nasdaq: ULTA]) will host its 2016 analyst and investor conference today, Thursday, October 13, 2016 from 10:00 a.m. to 3:00 p.m. in Chicago, Illinois. In conjunction with this event, the Company raised its financial guidance for the third quarter and full year 2016, and provided an update on its long term strategy.
We look forward to sharing with the investment community our latest thinking on our strategic plan and opportunities to double our market share, said Mary Dillon, Chief Executive Officer. We are confident that executing against our strategic imperatives will continue to drive excellent financial results and create sustainable, long... More
Morgan Stanley Remains Sidelined on Ulta Salon (ULTA) Ahead of Analyst Day
October 11, 2016 2:47 PM EDTMorgan Stanley reiterated an Equalweight rating and $250.00 price target on ULTA Salon (NASDAQ: ULTA) ahead of the company's analyst day.
Analyst Simeon Gutman commented, "Much of the good news we expect to hear at Thursday's Analyst Day is reflected in... More
